Molina Arturo MD's Form 4 filing
Protagonist Therapeutics, Inc (PTGX) · filed Nov 27, 2024
- Accession no.
- 0001104659-24-123809
- Filed
- Nov 27, 2024
- Trade date
- Nov 26-27, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.41M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Molina Arturo MDCIK 0001398940 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | Common Stock | MOption exerciseAcquired | +5,529 | $8.04 | +$44,453.16 | 51,973 | Direct | |
| Nov 26, 2024 | Common Stock | SSaleDisposed | −5,529 | $45.60 | −$252,122.4 | 46,444 | Direct | |
| Nov 27, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $8.04 | +$80,400 | 56,444 | Direct | |
| Nov 27, 2024 | Common Stock | SSaleDisposed | −10,000 | $44.50 | −$445,000 | 46,444 | Direct | |
| Nov 27, 2024 | Common Stock | MOption exerciseAcquired | +16,000 | $8.04 | +$128,640 | 62,444 | Direct | |
| Nov 27, 2024 | Common Stock | SSaleDisposed | −16,000 | $44.83 | −$717,280 | 46,444 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | Common Stock | MOption exerciseDisposed | −5,529 | $0.00 | $0 | 121,971 | Direct | |
| Nov 27, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 111,971 | Direct | |
| Nov 27, 2024 | Common Stock | MOption exerciseDisposed | −16,000 | $0.00 | $0 | 95,971 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.